Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Atopic eczema: Management

By Christine Clark, PhD, FRPharmS

Managing eczemaThe education of patients and their carers on avoiding trigger factors, using emollients effectively and adopting a stepped management plan is essential for successful treatment of eczema.


The treatment of atopic eczema is centred around identification and avoidance of trigger factors, effective use of emollients and the implementation of a stepped-care plan for managing flares.

The stepped-care model involves identifying the severity of a patient’s eczema at any particular time and providing treatment as appropriate.

Mild atopic eczema can usually be managed with emollients alone or in combination with topical corticosteroids. Moderate eczema may require the addition of immunotherapeutic medicines such as topical tacrolimus. Systemic immunosuppressants might be needed for severe atopic eczema.


Christine Clark is a freelance journalist and chairman of the Skin Care Campaign, a UK organisation representing the interests of people with skin diseases.


Citation: Clinical Pharmacist URI: 11023454

Readers' comments (2)

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary information

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.